George Imataka

1.7k total citations
96 papers, 1.0k citations indexed

About

George Imataka is a scholar working on Pediatrics, Perinatology and Child Health, Infectious Diseases and Molecular Biology. According to data from OpenAlex, George Imataka has authored 96 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Pediatrics, Perinatology and Child Health, 22 papers in Infectious Diseases and 20 papers in Molecular Biology. Recurrent topics in George Imataka's work include Infectious Encephalopathies and Encephalitis (18 papers), Bacterial Infections and Vaccines (12 papers) and Prenatal Screening and Diagnostics (11 papers). George Imataka is often cited by papers focused on Infectious Encephalopathies and Encephalitis (18 papers), Bacterial Infections and Vaccines (12 papers) and Prenatal Screening and Diagnostics (11 papers). George Imataka collaborates with scholars based in Japan, United States and Italy. George Imataka's co-authors include Osamu Arisaka, Kunio Yui, Hideo Yamanouchi, Shigemi Yoshihara, Hiroshi Suzumura, Akihisa Okumura, Masashi Mizuguchi, Yoshihiro Maegaki, Hiroyuki Nakamura and Naoki Ohara and has published in prestigious journals such as SHILAP Revista de lepidopterología, Neurology and International Journal of Molecular Sciences.

In The Last Decade

George Imataka

87 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
George Imataka Japan 16 373 226 218 166 162 96 1.0k
Tohru Okanishi Japan 18 284 0.8× 229 1.0× 271 1.2× 135 0.8× 540 3.3× 155 1.4k
I‐Ching Chou Taiwan 21 103 0.3× 293 1.3× 297 1.4× 50 0.3× 461 2.8× 101 1.4k
Mark Nespeca United States 16 141 0.4× 279 1.2× 366 1.7× 55 0.3× 386 2.4× 28 1.2k
Manuel Castro‐Gago Spain 21 106 0.3× 367 1.6× 471 2.2× 30 0.2× 413 2.5× 105 1.4k
J. E. Bell United Kingdom 22 447 1.2× 864 3.8× 85 0.4× 40 0.2× 111 0.7× 35 2.4k
Paul Dyken United States 27 263 0.7× 489 2.2× 333 1.5× 56 0.3× 345 2.1× 58 2.1k
Suvasini Sharma India 21 119 0.3× 279 1.2× 442 2.0× 38 0.2× 699 4.3× 177 1.9k
Shay Menascu Israel 20 465 1.2× 198 0.9× 83 0.4× 19 0.1× 309 1.9× 77 1.6k
Akimasa Okuno Japan 21 102 0.3× 373 1.7× 128 0.6× 39 0.2× 54 0.3× 80 1.3k
Wen‐Xiong Chen China 13 69 0.2× 99 0.4× 102 0.5× 38 0.2× 109 0.7× 58 699

Countries citing papers authored by George Imataka

Since Specialization
Citations

This map shows the geographic impact of George Imataka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George Imataka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George Imataka more than expected).

Fields of papers citing papers by George Imataka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by George Imataka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George Imataka. The network helps show where George Imataka may publish in the future.

Co-authorship network of co-authors of George Imataka

This figure shows the co-authorship network connecting the top 25 collaborators of George Imataka. A scholar is included among the top collaborators of George Imataka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with George Imataka. George Imataka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Imataka, George, Shigeko Kuwashima, Shujiro Hayashi, et al.. (2025). Neurofibromatosis Type 1 and MEK Inhibition: A Comprehensive Review with Focus on Selumetinib Therapy. Journal of Clinical Medicine. 14(14). 5071–5071. 1 indexed citations
3.
Imataka, George & Hideaki Shiraishi. (2024). Youth Suicide in Japan: Exploring the Role of Subcultures, Internet Addiction, and Societal Pressures. SHILAP Revista de lepidopterología. 13(1). 2–2. 2 indexed citations
4.
Yui, Kunio, George Imataka, & Tadashi Shiohama. (2023). Lipid Peroxidation via Regulating the Metabolism of Docosahexaenoic Acid and Arachidonic Acid in Autistic Behavioral Symptoms. Current Issues in Molecular Biology. 45(11). 9149–9164. 2 indexed citations
5.
Fujita, Yuji, Shigeko Kuwashima, George Imataka, et al.. (2023). Whole-body MRI revealed generalized subcutaneous oedema in a patient with juvenile dermatomyositis. Rheumatology Advances in Practice. 7(2). rkad063–rkad063. 1 indexed citations
6.
Imataka, George, et al.. (2023). Brain Hypothermia Therapy and Targeted Temperature Management for Acute Encephalopathy in Children: Status and Prospects. Journal of Clinical Medicine. 12(6). 2095–2095. 5 indexed citations
7.
Arisaka, Osamu, Yukiko Shimada, Yoshiya Ito, et al.. (2021). Brain Sexual Differentiation and Gender Development. 48(1). 1–7.
8.
Mizuguchi, Masashi, Takashi Ichiyama, George Imataka, et al.. (2020). Guidelines for the diagnosis and treatment of acute encephalopathy in childhood. Brain and Development. 43(1). 2–31. 84 indexed citations
9.
Yui, Kunio, George Imataka, Hitomi Sasaki, & Ryoichi Shiroki. (2020). The role of lipid peroxidation in individuals with autism spectrum disorders. Metabolic Brain Disease. 35(7). 1101–1108. 8 indexed citations
10.
Imataka, George & Shigemi Yoshihara. (2017). Sociological histories on epilepsy as "causes for disqualification" stipulated in the Japanese Road Traffic Act of 1960 and Revised Road Traffic Act of 2001.. PubMed. 21(13). 3098–3104. 2 indexed citations
11.
Imataka, George, et al.. (2016). Epilepsy-related automobile accidents in Japan: legal changes about a precedent and penal regulations.. PubMed. 20(3). 491–7. 7 indexed citations
12.
Imataka, George, et al.. (2015). Del(18)(q12.2q21.1) syndrome: a case report and clinical review of the literature.. PubMed. 19(17). 3241–5. 7 indexed citations
13.
Imataka, George & Osamu Arisaka. (2015). Brain hypothermia therapy for childhood acute encephalopathy based on clinical evidence. Experimental and Therapeutic Medicine. 10(5). 1624–1626. 4 indexed citations
14.
Imataka, George & Osamu Arisaka. (2014). Long-Term, High-Dose Intravenous Immunoglobulin Therapy in a Patient with Banker-Type Juvenile Dermatomyositis. Cell Biochemistry and Biophysics. 69(3). 747–748. 7 indexed citations
15.
Imataka, George, Hideo Yamanouchi, Junko Hirato, et al.. (2013). Autopsy Report of a 7-Year Old Patient with the Mosaic Trisomy 13. Cell Biochemistry and Biophysics. 67(2). 813–817. 3 indexed citations
16.
Imataka, George, Osamu Sakamoto, Hideo Yamanouchi, et al.. (2013). Novel c.2216T > C (p.I739T) Mutation in Exon 13 and c.1481T > A (p.L494X) Mutation in Exon 8 of MUT Gene in a Female with Methylmalonic Acidemia. Cell Biochemistry and Biophysics. 67(1). 185–187. 6 indexed citations
17.
Imataka, George, Yoshiyuki Watabe, & Osamu Arisaka. (2012). Clinically Mild form of Joubert Syndrome-related Disorder in a 7-year-old Female:A case report. 39(2). 119–122. 1 indexed citations
18.
Imataka, George, et al.. (2010). Clinical features and subdural lesions in childhood onset Haemophilus influenzae meningitis. 37(3). 173–180.
19.
Imataka, George, et al.. (2010). Lennox-Gastaut Syndrome Associated with Unilateral Hemispheric Porencephaly. 37(2). 125–128. 1 indexed citations
20.
Imataka, George, Hideo Yamanouchi, & Osamu Arisaka. (2007). Dandy–Walker syndrome and chromosomal abnormalities. Congenital Anomalies. 47(4). 113–118. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026